Short Communication - Journal of Translational Research (2020) Volume 4, Issue 3
One-year results of half-dose photodynamic therapy versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy
To think about the adequacy of half-portion photodynamic Therapy (PDT) and 33% portion PDT in therapy in constant or repeat Central Serous Chorioretinopathy (CSC).
Laser photocoagulation is commonly used to treat extrafoveal spillage. Nonetheless, interminable CSC, with expansive or undefined spillage, and CSC with subfoveal or juxtafoveal spillage are hard to treat with laser photocoagulation on account of trouble in confining the spillage point and the chance of genuine intricacies, for example, RPE decay, changeless scotoma and optional choroidal neovascularization (CNV).